Quantifying the effects of prior acetyl-salicylic acid on sepsis-related deaths: An individual patient data meta-analysis using propensity matching

James Trauer, Stephen Muhi, Emma S. McBryde, Shmeylan A. Al Harbi, Yaseen M. Arabi, Andrew J. Boyle, Rodrigo Cartin-Ceba, Wei Chen, Yung Tai Chen, Marco Falcone, Ognjen Gajic, Jack Godsell, Michelle Ng Gong, Daryl Kor, Wolfgang Lösche, Daniel F. McAuley, Hollis R. O'Neal, Michael Osthoff, Gordon P. Otto, Maik SossdorfMin Juei Tsai, Juan C. Valerio-Rojas, Tom Van Der Poll, Francesco Violi, Lorraine Ware, Andreas F. Widmer, Maryse A. Wiewel, Johannes Winning, Damon P. Eisen

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Objective: The primary objective was to conduct a meta-analysis on published observational cohort data describing the association between acetyl-salicylic acid (aspirin) use prior to the onset of sepsis and mortality in hospitalized patients. Study Selection: Studies that reported mortality in patients on aspirin with sepsis with a comparison group of patients with sepsis not on prior aspirin therapy were included. Data Sources: Fifteen studies described hospital-based cohorts (n = 17,065), whereas one was a large insurance-based database (n = 683,421). Individual-level patient data were incorporated from all selected studies. Data Extraction: Propensity analyses with 1:1 propensity score matching at the study level were performed, using the most consistently available covariates judged to be associated with aspirin. Meta-analyses were performed to estimate the pooled average treatment effect of aspirin on sepsis-related mortality. Data Synthesis: Use of aspirin was associated with a 7% (95% CI, 2-12%; p = 0.005) reduction in the risk of death as shown by meta-analysis with considerable statistical heterogeneity (I2 = 61.6%). Conclusions: These results are consistent with effects ranging from a 2% to 12% reduction in mortality risk in patients taking aspirin prior to sepsis onset. This association anticipates results of defnitive studies of the use of low-dose aspirin as a strategy for reduction of deaths in patients with sepsis.

Original languageEnglish (US)
Pages (from-to)1871-1879
Number of pages9
JournalCritical care medicine
Volume45
Issue number11
DOIs
StatePublished - Nov 2017

Keywords

  • Acetyl-salicylic acid
  • Aspirin
  • Death
  • Mortality
  • Sepsis

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Quantifying the effects of prior acetyl-salicylic acid on sepsis-related deaths: An individual patient data meta-analysis using propensity matching'. Together they form a unique fingerprint.

  • Cite this

    Trauer, J., Muhi, S., McBryde, E. S., Al Harbi, S. A., Arabi, Y. M., Boyle, A. J., Cartin-Ceba, R., Chen, W., Chen, Y. T., Falcone, M., Gajic, O., Godsell, J., Gong, M. N., Kor, D., Lösche, W., McAuley, D. F., O'Neal, H. R., Osthoff, M., Otto, G. P., ... Eisen, D. P. (2017). Quantifying the effects of prior acetyl-salicylic acid on sepsis-related deaths: An individual patient data meta-analysis using propensity matching. Critical care medicine, 45(11), 1871-1879. https://doi.org/10.1097/CCM.0000000000002654